Overview
Makers Laboratories Limited (MLL) is a pharmaceutical company involved in manufacturing formulations and drug intermediates.
The company has a history of strategic mergers and expansions to increase its production capacity and market presence.
MLL's recent focus includes manufacturing diabetic, hypertensive treatments, and ophthalmic eye drops, indicating a strategy to diversify its product range.
Modernization efforts, including upgrading its liquid injectable unit, suggest ongoing investment in expanding and enhancing production capabilities.
The acquisition of Resonance Specialties Limited highlights MLL's strategic approach towards enhancing its footprint and operational scale.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
93 Cr
- Volatility
Low Risk
- P/E Ratio
72.7
- Industry P/E
32.3
- PEG Ratio
0.4
- P/B Ratio
1.3
- 52W High
173.70
- 52W Low
109.00
Financial Ratios
Sales CAGR
- 1Y
- 15.67%
- 3Y
- -6.40%
- 5Y
- -3.53%
- 10Y
- -4.13%
Profit CAGR
- 1Y
- 326.82%
- 3Y
- 200.05%
- 5Y
- —
- 10Y
- 8.08%
ROE
- TTM
- -0.03%
- 3Y
- -5.23%
- 5Y
- -3.81%
- 10Y
- 0.28%
ROCE
- TTM
- 8.67%
- 3Y
- -2.66%
- 5Y
- -1.13%
- 10Y
- 2.96%
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
